Voir la vidéoWatch the full video
100
100

Management ownership 100%

1
1

Turnover billion €

5
5

World Top 5

6000
6000

Headcount

News
Delpharm continues its growth in Europe with the acquisition of state-of-the-art drug production facilities in the Netherlands, from Astellas.

World-leading CDMO Delpharm expands its pharmaceutical network with the acquisition from Astellas of the Meppel pharmaceutical manufacturing facility.

Prefilled syringes
With Delpharm Leiden development center and Tours experts, we can support you in the development and manufacture of prefilled syringes. We have the capacity to produce between 25 and 30 million syringes a year in sizes ranging from 1ml to 50ml.
Regulatory affairs
A full team dedicated to support you in the long term or for emergency needs.
Read more...

Customer references

Takeda
Teva
HRA Pharma
Aguettant
Mylan
LFB
Servier
Daiichi-Sankyo
OM Pharma
Genfit
Merck
Sanofi
Sanionia
Urgo
Boehringer Indelheim
Cooper
Bayer
Zentiva
Eisai
Aurobindo
Bracco
Meda
Biogaran
GlaxoSmithKline
Sandoz
Novartis
Zoetis
Biocodex